Home›People›Daniel Becker
DB

Daniel Becker

Director at Matchpoint Therapeutics and managing director at Access Biotechnology.

Director
Updated Nov 20, 2026·Latest SEC filing Nov 20, 2026·Suggest an edit

About Daniel Becker

Daniel Becker is a Matchpoint Therapeutics director. The company develops drugs for immune diseases. He is also managing director at Access Biotechnology.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Becker in the role, so the role may have started earlier or lasted longer.

Matchpoint Therapeutics Inc. Current
Director; Managing Director, Access Biotechnology
2022 – Present · Watertown, MA
Matchpoint develops oral drugs that bind hard-to-treat protein targets in immune diseases.
Access Biotechnology Current
Managing Director

Key Colleagues at Startups

The people Daniel Becker works with at each company, as listed on that company's latest Form D.

Matchpoint Therapeutics Inc. · Form D, Nov 20, 2026
Andre Turenne
Andre Turenne
Director; President & Chief Executive Officer
BM
Brian Matesic
Director; Principal, Norwest
KP
Kanishka Pothula
Director; Managing Partner, Nextech
JH
Jason Hafler
Director; Managing Director, Sanofi Ventures
BB
Bruce Booth
Chairman; Partner, Atlas Venture
DN
Jared Cumming
Jared Cumming
Chief Scientific Officer
John O'Malley
John O'Malley
Chief Medical Officer

Sources

  1. SECMatchpoint Therapeutics Inc. Form D, filed Nov 20, 2026